http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114404495-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f1410e5e217d21eee98a8b12cfe2604a
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-232
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-804
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-185
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-238
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2068
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-59
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-344
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-484
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-21
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-804
filingDate 2021-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5aad4f93f579b396373dcbd44b1707b5
publicationDate 2022-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-114404495-A
titleOfInvention Traditional Chinese medicine composition for treating rheumatoid arthritis and its application and pill and its preparation method and application
abstract The invention relates to a traditional Chinese medicine composition for treating rheumatoid arthritis. The traditional Chinese medicinal composition contains the following raw materials: Qingfengteng, Fangfeng, licorice, tucca, Rehmannia glutinosa, Achyranthes, Angelica sinensis and Codonopsis pilosula. The traditional Chinese medicine composition has wide drug sources, low cost, little toxic and side effects, and can effectively treat rheumatoid arthritis. The present invention also provides a pill containing the traditional Chinese medicine composition. The pill is low in manufacturing cost, simple in process and easy to be accepted by patients.
priorityDate 2021-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527139
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14982

Total number of triples: 25.